- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Article
POLL: Are You Attending South Beach Symposium?
Author(s):
Key Takeaways
- Personalized treatment strategies have advanced the management of lung cancer brain metastases, improving patient outcomes.
- Targeted therapies and immunotherapies offer new hope, with molecular profiling and advanced imaging enabling precise treatment planning.
Click here to answer this week's poll.
Are You Attending South Beach Symposium?
If you can't attend South Beach Symposium, click here to sign up for conference eNewsletters from Dermatology Times® to receive all coverage updates.
Related Videos
Mastering Dermoscopy and Dysplastic Nevi
Improving Acne Treatment Through Antibiotic Stewardship and Gut-Skin Health
Addressing Ongoing Benzoyl Peroxide and Benzene Updates at AAD 2025
Reviewing 3 Key Lebrikizumab Abstracts From AAD 2025
How to Avoid Complications With Radiofrequency and Ultrasound-Based Technologies
Michael Gold, MD: Insights on Silicone, Energy-Based Devices, and Radiation Therapy
Expert Insights Into L'Oréal’s Voluntary Recall of Benzoyl Peroxide Products
Jeff Stark, MD: Discussing Bimzelx’s Efficacy and Future in Treating Inflammatory Skin Diseases
Michael Gold, MD: Mastering Device Complications and the Importance of Preparedness in Dermatology
Adewole Adamson, MD, MPP: Exploring Key Controversies in Dermatology at the 2025 AAD Annual Meeting
Related Content
